ATH 33.3% 0.4¢ alterity therapeutics limited

During many past years, Kempler has not been so convinced as he...

  1. 2,840 Posts.
    lightbulb Created with Sketch. 995
    During many past years, Kempler has not been so convinced as he was last Friday:

    “We believe that our science is unique, validated, and is capturing the attention of physicians and
    researchers for its potential to have a positive impact on the lives of many people suffering from
    Parkinsonian diseases which currently have no cure.”

    Unfortunately, ATH has not told us much but the Finkelstein paper almost 3.5 years ago and a couple of Stamler's posters. In a way, I trust that they have something unique, but my opinion is only an opinion without specific ATH434 study results Kempler already has, most likely, at last from phase 1.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.001(33.3%)
Mkt cap ! $21.28M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $34 10K

Buyers (Bids)

No. Vol. Price($)
28 17196248 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 130790145 27
View Market Depth
Last trade - 16.10pm 04/10/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.